+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Vaccine Vials Market Research Report by Type (Multi Dose and Single Dose), Material, Capacity, Application, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 120 Pages
  • July 2022
  • Region: United States
  • 360iResearch™
  • ID: 5239948
UP TO OFF until Dec 31st 2022
The United States Vaccine Vials Market size was estimated at USD 104.72 million in 2021, USD 121.75 million in 2022, and is projected to grow at a CAGR 12.61% to reach USD 213.66 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Vaccine Vials to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market was studied across Multi Dose and Single Dose.
  • Based on Material, the market was studied across Glass and Polymer.
  • Based on Capacity, the market was studied across 10ml, 20ml, 2ml, 3ml, and 5ml.
  • Based on Application, the market was studied across Preventive Vaccine and Therapeutic Vaccine.
  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Vaccine Vials market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Vaccine Vials Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Vaccine Vials Market, including Anhui Huaxin Medicinal Glass Products Co., Ltd., Berlin Packaging LLC, Cardinal Health, Inc., Catalent, Inc., Corning Inc., DWK Life Sciences GmbH, Gerresheimer AG, Jinan Youlyy Industrial Co., Ltd., JOTOP Glass, Nipro Corporation, Origin Pharmaceuticals Ltd, Pacific Vial Manufacturing Inc., Qorpak, Inc., Richland Glass Company, Inc., SCHOTT AG, Shandong Pharmaceutical Glass Co., Ltd., SiO2 Medical Products, Stevanato Group, Thermo Fisher Scientific Inc, and Vetter Pharma-Fertigung GmbH & Co. KG..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the United States Vaccine Vials Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Vaccine Vials Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Vaccine Vials Market?
4. What is the competitive strategic window for opportunities in the United States Vaccine Vials Market?
5. What are the technology trends and regulatory frameworks in the United States Vaccine Vials Market?
6. What is the market share of the leading vendors in the United States Vaccine Vials Market?
7. What modes and strategic moves are considered suitable for entering the United States Vaccine Vials Market?
Frequently Asked Questions about the U.S. Vaccine Vials Market

What is the estimated value of the U.S. Vaccine Vials Market?

The U.S. Vaccine Vials Market was estimated to be valued at $104.72 Million in 2021.

What is the growth rate of the U.S. Vaccine Vials Market?

The growth rate of the U.S. Vaccine Vials Market is 12.6%, with an estimated value of $213.66 Million by 2027.

What is the forecasted size of the U.S. Vaccine Vials Market?

The U.S. Vaccine Vials Market is estimated to be worth $213.66 Million by 2027.

Who are the key companies in the U.S. Vaccine Vials Market?

Key companies in the U.S. Vaccine Vials Market include Anhui Huaxin Medicinal Glass Products Co., Ltd., Berlin Packaging LLC, Cardinal Health, Inc., Catalent, Inc., Corning Inc., DWK Life Sciences GmbH, Gerresheimer AG, Jinan Youlyy Industrial Co., Ltd. and Nipro Corporation.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
6. Vaccine Vials Market, by Type
6.1. Introduction
6.2. Multi Dose
6.3. Single Dose
7. Vaccine Vials Market, by Material
7.1. Introduction
7.2. Glass
7.3. Polymer
8. Vaccine Vials Market, by Capacity
8.1. Introduction
8.2. 10ml
8.3. 20ml
8.4. 2ml
8.5. 3ml
8.6. 5ml
9. Vaccine Vials Market, by Application
9.1. Introduction
9.2. Preventive Vaccine
9.3. Therapeutic Vaccine
10. California Vaccine Vials Market11. Florida Vaccine Vials Market12. Illinois Vaccine Vials Market13. New York Vaccine Vials Market14. Ohio Vaccine Vials Market15. Pennsylvania Vaccine Vials Market16. Texas Vaccine Vials Market
17. Competitive Landscape
17.1. FPNV Positioning Matrix
17.1.1. Quadrants
17.1.2. Business Strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis
17.3. Market Share Analysis, By Key Player
17.4. Competitive Scenario
17.4.1. Merger & Acquisition
17.4.2. Agreement, Collaboration, & Partnership
17.4.3. New Product Launch & Enhancement
17.4.4. Investment & Funding
17.4.5. Award, Recognition, & Expansion
18. Company Usability Profiles
18.1. Anhui Huaxin Medicinal Glass Products Co., Ltd.
18.2. Berlin Packaging LLC
18.3. Cardinal Health, Inc.
18.4. Catalent, Inc.
18.5. Corning Inc.
18.6. DWK Life Sciences GmbH
18.7. Gerresheimer AG
18.8. Jinan Youlyy Industrial Co., Ltd.
18.9. JOTOP Glass
18.10. Nipro Corporation
18.11. Origin Pharmaceuticals Ltd
18.12. Pacific Vial Manufacturing Inc.
18.13. Qorpak, Inc.
18.14. Richland Glass Company, Inc.
18.15. SCHOTT AG
18.16. Shandong Pharmaceutical Glass Co., Ltd.
18.17. SiO2 Medical Products
18.18. Stevanato Group
18.19. Thermo Fisher Scientific Inc
18.20. Vetter Pharma-Fertigung GmbH & Co. KG.
19. Appendix
19.1. Discussion Guide
19.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES VACCINE VIALS MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES VACCINE VIALS MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. UNITED STATES VACCINE VIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. UNITED STATES VACCINE VIALS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 5. UNITED STATES VACCINE VIALS MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES VACCINE VIALS MARKET SIZE, BY STATE, 2027
FIGURE 7. UNITED STATES VACCINE VIALS MARKET DYNAMICS
FIGURE 8. UNITED STATES VACCINE VIALS MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 9. UNITED STATES VACCINE VIALS MARKET SIZE, BY TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES VACCINE VIALS MARKET SIZE, BY TYPE, 2027
FIGURE 11. UNITED STATES VACCINE VIALS MARKET SIZE, BY MULTI DOSE, 2019-2027 (USD MILLION)
FIGURE 12. UNITED STATES VACCINE VIALS MARKET SIZE, BY MULTI DOSE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 13. UNITED STATES VACCINE VIALS MARKET SIZE, BY SINGLE DOSE, 2019-2027 (USD MILLION)
FIGURE 14. UNITED STATES VACCINE VIALS MARKET SIZE, BY SINGLE DOSE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 15. UNITED STATES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2021 VS 2027 (%)
FIGURE 16. UNITED STATES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2021 VS 2027 (USD MILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2027
FIGURE 18. UNITED STATES VACCINE VIALS MARKET SIZE, BY GLASS, 2019-2027 (USD MILLION)
FIGURE 19. UNITED STATES VACCINE VIALS MARKET SIZE, BY GLASS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 20. UNITED STATES VACCINE VIALS MARKET SIZE, BY POLYMER, 2019-2027 (USD MILLION)
FIGURE 21. UNITED STATES VACCINE VIALS MARKET SIZE, BY POLYMER, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 22. UNITED STATES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2021 VS 2027 (%)
FIGURE 23. UNITED STATES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2021 VS 2027 (USD MILLION)
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2027
FIGURE 25. UNITED STATES VACCINE VIALS MARKET SIZE, BY 10ML, 2019-2027 (USD MILLION)
FIGURE 26. UNITED STATES VACCINE VIALS MARKET SIZE, BY 10ML, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 27. UNITED STATES VACCINE VIALS MARKET SIZE, BY 20ML, 2019-2027 (USD MILLION)
FIGURE 28. UNITED STATES VACCINE VIALS MARKET SIZE, BY 20ML, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 29. UNITED STATES VACCINE VIALS MARKET SIZE, BY 2ML, 2019-2027 (USD MILLION)
FIGURE 30. UNITED STATES VACCINE VIALS MARKET SIZE, BY 2ML, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 31. UNITED STATES VACCINE VIALS MARKET SIZE, BY 3ML, 2019-2027 (USD MILLION)
FIGURE 32. UNITED STATES VACCINE VIALS MARKET SIZE, BY 3ML, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 33. UNITED STATES VACCINE VIALS MARKET SIZE, BY 5ML, 2019-2027 (USD MILLION)
FIGURE 34. UNITED STATES VACCINE VIALS MARKET SIZE, BY 5ML, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 35. UNITED STATES VACCINE VIALS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 36. UNITED STATES VACCINE VIALS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES VACCINE VIALS MARKET SIZE, BY APPLICATION, 2027
FIGURE 38. UNITED STATES VACCINE VIALS MARKET SIZE, BY PREVENTIVE VACCINE, 2019-2027 (USD MILLION)
FIGURE 39. UNITED STATES VACCINE VIALS MARKET SIZE, BY PREVENTIVE VACCINE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 40. UNITED STATES VACCINE VIALS MARKET SIZE, BY THERAPEUTIC VACCINE, 2019-2027 (USD MILLION)
FIGURE 41. UNITED STATES VACCINE VIALS MARKET SIZE, BY THERAPEUTIC VACCINE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 42. CALIFORNIA VACCINE VIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 43. FLORIDA VACCINE VIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 44. ILLINOIS VACCINE VIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 45. NEW YORK VACCINE VIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 46. OHIO VACCINE VIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 47. PENNSYLVANIA VACCINE VIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 48. TEXAS VACCINE VIALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 49. UNITED STATES VACCINE VIALS MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 50. UNITED STATES VACCINE VIALS MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 51. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES VACCINE VIALS MARKET, BY TYPE
List of Tables
TABLE 1. UNITED STATES VACCINE VIALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES VACCINE VIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. UNITED STATES VACCINE VIALS MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 5. UNITED STATES VACCINE VIALS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES VACCINE VIALS MARKET SIZE, BY MULTI DOSE, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. UNITED STATES VACCINE VIALS MARKET SIZE, BY SINGLE DOSE, BY STATE, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES VACCINE VIALS MARKET SIZE, BY MATERIAL, 2019-2027 (USD MILLION)
TABLE 9. UNITED STATES VACCINE VIALS MARKET SIZE, BY GLASS, BY STATE, 2019-2027 (USD MILLION)
TABLE 10. UNITED STATES VACCINE VIALS MARKET SIZE, BY POLYMER, BY STATE, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES VACCINE VIALS MARKET SIZE, BY CAPACITY, 2019-2027 (USD MILLION)
TABLE 12. UNITED STATES VACCINE VIALS MARKET SIZE, BY 10ML, BY STATE, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES VACCINE VIALS MARKET SIZE, BY 20ML, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. UNITED STATES VACCINE VIALS MARKET SIZE, BY 2ML, BY STATE, 2019-2027 (USD MILLION)
TABLE 15. UNITED STATES VACCINE VIALS MARKET SIZE, BY 3ML, BY STATE, 2019-2027 (USD MILLION)
TABLE 16. UNITED STATES VACCINE VIALS MARKET SIZE, BY 5ML, BY STATE, 2019-2027 (USD MILLION)
TABLE 17. UNITED STATES VACCINE VIALS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES VACCINE VIALS MARKET SIZE, BY PREVENTIVE VACCINE, BY STATE, 2019-2027 (USD MILLION)
TABLE 19. UNITED STATES VACCINE VIALS MARKET SIZE, BY THERAPEUTIC VACCINE, BY STATE, 2019-2027 (USD MILLION)
TABLE 20. CALIFORNIA VACCINE VIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 21. CALIFORNIA VACCINE VIALS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 22. CALIFORNIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2019-2027 (USD MILLION)
TABLE 23. CALIFORNIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2019-2027 (USD MILLION)
TABLE 24. CALIFORNIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 25. FLORIDA VACCINE VIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 26. FLORIDA VACCINE VIALS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 27. FLORIDA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2019-2027 (USD MILLION)
TABLE 28. FLORIDA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2019-2027 (USD MILLION)
TABLE 29. FLORIDA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 30. ILLINOIS VACCINE VIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 31. ILLINOIS VACCINE VIALS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 32. ILLINOIS VACCINE VIALS MARKET SIZE, BY MATERIAL, 2019-2027 (USD MILLION)
TABLE 33. ILLINOIS VACCINE VIALS MARKET SIZE, BY CAPACITY, 2019-2027 (USD MILLION)
TABLE 34. ILLINOIS VACCINE VIALS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 35. NEW YORK VACCINE VIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 36. NEW YORK VACCINE VIALS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 37. NEW YORK VACCINE VIALS MARKET SIZE, BY MATERIAL, 2019-2027 (USD MILLION)
TABLE 38. NEW YORK VACCINE VIALS MARKET SIZE, BY CAPACITY, 2019-2027 (USD MILLION)
TABLE 39. NEW YORK VACCINE VIALS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 40. OHIO VACCINE VIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 41. OHIO VACCINE VIALS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 42. OHIO VACCINE VIALS MARKET SIZE, BY MATERIAL, 2019-2027 (USD MILLION)
TABLE 43. OHIO VACCINE VIALS MARKET SIZE, BY CAPACITY, 2019-2027 (USD MILLION)
TABLE 44. OHIO VACCINE VIALS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 45. PENNSYLVANIA VACCINE VIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 46. PENNSYLVANIA VACCINE VIALS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 47. PENNSYLVANIA VACCINE VIALS MARKET SIZE, BY MATERIAL, 2019-2027 (USD MILLION)
TABLE 48. PENNSYLVANIA VACCINE VIALS MARKET SIZE, BY CAPACITY, 2019-2027 (USD MILLION)
TABLE 49. PENNSYLVANIA VACCINE VIALS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 50. TEXAS VACCINE VIALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 51. TEXAS VACCINE VIALS MARKET SIZE, BY TYPE, 2019-2027 (USD MILLION)
TABLE 52. TEXAS VACCINE VIALS MARKET SIZE, BY MATERIAL, 2019-2027 (USD MILLION)
TABLE 53. TEXAS VACCINE VIALS MARKET SIZE, BY CAPACITY, 2019-2027 (USD MILLION)
TABLE 54. TEXAS VACCINE VIALS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 55. UNITED STATES VACCINE VIALS MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 56. UNITED STATES VACCINE VIALS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 57. UNITED STATES VACCINE VIALS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 58. UNITED STATES VACCINE VIALS MARKET RANKING
TABLE 59. UNITED STATES VACCINE VIALS MARKET SHARE, BY KEY PLAYER, 2021
TABLE 60. UNITED STATES VACCINE VIALS MARKET MERGER & ACQUISITION
TABLE 61. UNITED STATES VACCINE VIALS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 62. UNITED STATES VACCINE VIALS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 63. UNITED STATES VACCINE VIALS MARKET INVESTMENT & FUNDING
TABLE 64. UNITED STATES VACCINE VIALS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 65. UNITED STATES VACCINE VIALS MARKET: LICENSE & PRICING

Companies Mentioned

  • Anhui Huaxin Medicinal Glass Products Co., Ltd.
  • Berlin Packaging LLC
  • Cardinal Health, Inc.
  • Catalent, Inc.
  • Corning Inc.
  • DWK Life Sciences GmbH
  • Gerresheimer AG
  • Jinan Youlyy Industrial Co., Ltd.
  • JOTOP Glass
  • Nipro Corporation
  • Origin Pharmaceuticals Ltd
  • Pacific Vial Manufacturing Inc.
  • Qorpak, Inc.
  • Richland Glass Company, Inc.
  • SCHOTT AG
  • Shandong Pharmaceutical Glass Co., Ltd.
  • SiO2 Medical Products
  • Stevanato Group
  • Thermo Fisher Scientific Inc
  • Vetter Pharma-Fertigung GmbH & Co. KG.

Methodology

Loading
LOADING...